ALS Limited has announced an ordinary dividend of AUD 0.194 per share for the half-year ending September 2025, accompanied by a fully franked 30% component and a Dividend Reinvestment Plan with no discount.
ALS Limited reported a robust FY25 with 16% revenue growth to AUD 3 billion, underpinned by strong organic expansion and key acquisitions. Despite slight NPAT decline, the company advances its sustainability agenda and invests in global lab upgrades.
